E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer Journal Article


Authors: Minikes, A. M.; Song, Y.; Feng, Y.; Yoon, C.; Yoon, S. S.; Jiang, X.
Article Title: E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer
Abstract: Gastric cancer is the third most common cause of cancer-related death worldwide. Diffuse-type gastric cancer (DGC) is a particularly aggressive subtype that is both difficult to detect and treat. DGC is distinguished by weak cell–cell cohesion, most often due to loss of the cell adhesion protein E-cadherin, a common occurrence in highly invasive, metastatic cancer cells. In this study, we demonstrate that loss-of-function mutation of E-cadherin in DGC cells results in their increased sensitivity to the non-apoptotic, iron-dependent form of cell death, ferroptosis. Homophilic contacts between E-cadherin molecules on adjacent cells suppress ferroptosis through activation of the Hippo pathway. Furthermore, single nucleotide mutations observed in DGC patients that ablate the homophilic binding capacity of E-cadherin reverse the ability of E-cadherin to suppress ferroptosis in both cell culture and xenograft models. Importantly, although E-cadherin loss in cancer cells is considered an essential event for epithelial-mesenchymal transition and subsequent metastasis, we found that circulating DGC cells lacking E-cadherin expression possess lower metastatic ability, due to their increased susceptibility to ferroptosis. Together, this study suggests that E-cadherin is a biomarker predicting the sensitivity to ferroptosis of DGC cells, both in primary tumor tissue and in circulation, thus guiding the usage of future ferroptosis-inducing therapeutics for the treatment of DGC. © 2023, The Author(s), under exclusive licence to Springer Nature Limited.
Keywords: controlled study; protein expression; human cell; genetics; missense mutation; mutation; nonhuman; binding affinity; biomarkers; biological marker; mouse; metastasis; animal experiment; animal model; genetic transcription; tumor xenograft; pathology; uvomorulin; cell culture; cell density; point mutation; site directed mutagenesis; cadherin; cadherins; loss of function mutation; stomach neoplasms; stomach tumor; epithelial mesenchymal transition; ferroptosis; humans; human; article; hippo signaling; yap signaling protein; diffuse-type gastric carcinoma
Journal Title: Oncogene
Volume: 42
Issue: 11
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2023-03-10
Start Page: 848
End Page: 857
Language: English
DOI: 10.1038/s41388-023-02599-5
PUBMED: 36717701
PROVIDER: scopus
PMCID: PMC10291936
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding author is MSK author Xuejun Jiang -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sam Yoon
    108 Yoon
  2. Xuejun Jiang
    121 Jiang
  3. Changhwan Yoon
    41 Yoon
  4. Yan   Feng
    6 Feng
  5. Yu Song
    1 Song